Mr. John Archibald reports
CO2 GRO INC. ANNOUNCES POSITIVE TOBACCO GROW TRIAL RESULTS FOR A BIOPHARMA COMPANY
CO2 Gro Inc. has released statistically significant positive results from a tobacco plant R&D (research and development) grow trial for a biopharmaceutical company. The customer, which has requested not to be named, as per the non-disclosure agreement signed by the parties, currently produces and sells a human drug that is extracted from inoculating young tobacco plant leaves with a specific bacterium. The customer also has a pipeline of other human drugs in development that will be produced using the same plant inoculation process.
The trial was conducted by the University of Guelph. Preinoculated tobacco plants were grown using the company's CO2 (carbon dioxide) delivery solutions versus a control of no CO2. The results in the attached table once again confirm CO2 delivery solutions' ability to significantly enhance the growth of leafy plants.
Measure Percentage increase/decrease
Wet weight 112%
Dry weight 133%
Leaf area 147%
Numerous other biopharmaceutical companies around the world are producing high-value medicines and vaccines extracted from inoculated or genetically modified tobacco, potato or other leaves. As a 2018 article from the TechnologyWorks website describes, tobacco plants can become "organic mini-factories producing vaccines and new drugs."
John Archibald, chief executive officer, commented: "The results once again underscore the effectiveness of CO2 delivery solutions on a variety of plants. Our biopharma customer will now conduct a grow trial on postinoculated tobacco plants using CO2 delivery solutions to assess the impact on increased medicinal content in the plant. Upon a successful postinoculation trial, the discussion with the customer will progress towards a commercial installation at their facility and open the market to other similar customers in the industry."
About CO2 Gro Inc.
The company's mission is to accelerate all indoor and outdoor value plant growth naturally, safely and economically using its patented and advanced CO2 delivery solutions technology.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.